Lite Strategy, Inc. — Director's Dealing 2015

Jul 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2015-07-28

Reporting Person: GOLD DANIEL P PHD (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-28	Option to purchase shares of common stock	$1.57	A	307500	Acquired	2025-07-28	Common Stock par value $0.00000002 (307500)	Direct

Footnotes

F1: The options will vest in equal monthly installments over 36 months.

F2: The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.